원내감염 시장 규모, 점유율, 성장 분석 : 유형별, 치료법별, 감염 유형별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Hospital-Acquired Infections Market size was valued at USD 30.86 Billion in 2024 and is poised to grow from USD 31.32 Billion in 2025 to USD 35.28 Billion by 2033, growing at a CAGR of 1.5% during the forecast period (2026-2033).

The hospital-acquired infections market is driven by the prevalence of microorganisms, such as viruses, bacteria, fungi, and parasites, which can lead to numerous infections, including respiratory, gastrointestinal, and skin-related conditions. The transmission of these infections often occurs through cross-contamination from patients, healthcare staff, and medical equipment. A variety of products and services, including sterilization, disinfection solutions, protective barriers, and endoscope reprocessing tools, are crucial for managing these infections. Factors propelling market growth include heightened awareness of hospital-acquired infections, the imperative to minimize cross-infection rates, rising cases of infectious diseases, and government initiatives supporting infection control measures. Additionally, the adoption of stringent infection prevention protocols and the integration of advanced monitoring technologies contribute significantly to market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hospital-Acquired Infections market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hospital-Acquired Infections Market Segments Analysis

Global Hospital-Acquired Infections Market is segmented by Type, Treatment, Infection Type, End User and region. Based on Type, the market is segmented into Equipment, Consumables and Services. Based on Treatment, the market is segmented into Antibacterial, Antiviral, Antifungal and Others. Based on Infection Type, the market is segmented into Bloodstream Infections, Ventilator-Associated Pneumonia (VAP), Urinary Tract Infection, Surgical-Site Infection, Gastrointestinal Infections and Others. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hospital-Acquired Infections Market

The rising prevalence of surgical procedures globally has led to an increased need for various surgical instruments and medical devices. Factors contributing to this rise include the growing rates of obesity, lifestyle-related illnesses, an aging demographic, and a surge in spine and sports-related injuries. Consequently, as these procedures become more common, the demand for sterilized equipment and medical devices intensifies. Enhanced awareness regarding the importance of sterilization and infection control in healthcare environments is further driving the demand for services related to hospital-acquired infections. This trend underscores the critical nature of maintaining high standards of hygiene in medical settings.

Restraints in the Global Hospital-Acquired Infections Market

The reprocessing of reusable medical devices presents both financial benefits and waste reduction for healthcare providers but also raises significant safety and efficacy concerns. Devices such as surgical forceps, endoscopes, and stethoscopes may harbor residual blood and tissue if not properly cleaned and sterilized, thereby elevating the risk of surgical site infections (SSIs) in patients. The presence of this biological debris can allow harmful microorganisms to survive through subsequent disinfection attempts, potentially resulting in hospital-acquired infections (HAIs). Additionally, residual chemicals from reprocessing can irritate tissue, further complicating patient care. Consequently, these issues hinder the widespread acceptance of reprocessing practices among hospital administrators and clinicians.

Market Trends of the Global Hospital-Acquired Infections Market

The Global Hospital-Acquired Infections market is experiencing significant growth driven by the rising incidence of chronic diseases such as diabetes, cardiovascular disorders, and cancer, largely attributed to factors like environmental pollution and unhealthy lifestyles. As the prevalence of these diseases continues to grow, the frequency of surgical procedures is also expected to increase, inevitably heightening the risk of hospital-acquired infections. Consequently, there is a greater demand for effective infection control devices and sterilization methods within healthcare facilities. This trend underscores the necessity for advanced solutions to mitigate infection transmission, ultimately propelling the market for hospital-acquired infection control products and technologies forward.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Hospital-Acquired Infections Market Size by Type & CAGR (2026-2033)

• Market Overview
• Equipment
  • Sterilization Equipment
  • Disinfection Equipment
• Consumables
  • Disinfectants
  • Sterilization Consumables
  • Others
• Services

Global Hospital-Acquired Infections Market Size by Treatment & CAGR (2026-2033)

• Market Overview
• Antibacterial
• Antiviral
• Antifungal
• Others

Global Hospital-Acquired Infections Market Size by Infection Type & CAGR (2026-2033)

• Market Overview
• Bloodstream Infections
• Ventilator-Associated Pneumonia (VAP)
• Urinary Tract Infection
• Surgical-Site Infection
• Gastrointestinal Infections
• Others

Global Hospital-Acquired Infections Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals & Clinics
• Ambulatory Surgical Centers
• Others

Global Hospital-Acquired Infections Market Size & CAGR (2026-2033)

• North America (Type, Treatment, Infection Type, End User)
  • US
  • Canada
• Europe (Type, Treatment, Infection Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Treatment, Infection Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Treatment, Infection Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Treatment, Infection Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• STERIS plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3M (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ecolab Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diversey Holdings, Ltd. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations